Profound Medical (PROF)
(Delayed Data from NSDQ)
$9.87 USD
-0.73 (-6.89%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $9.84 -0.03 (-0.30%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/8/24 |
---|---|
Current Quarter | -0.28 |
EPS Last Quarter | -0.26 |
Last EPS Surprise | 16.13% |
ABR | 1.40 |
Earnings ESP
|
9.64% |
---|---|
Current Year | -1.11 |
Next Year | -0.90 |
EPS (TTM) | -1.29 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.50M | 3.13M | 11.40M | 31.38M |
# of Estimates | 3 | 3 | 3 | 4 |
High Estimate | 2.70M | 3.20M | 11.60M | 45.90M |
Low Estimate | 2.30M | 3.10M | 11.10M | 19.30M |
Year ago Sales | 1.60M | 1.73M | 7.20M | 11.40M |
Year over Year Growth Est. | 56.25% | 81.10% | 58.36% | 175.22% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.28 | -0.29 | -1.11 | -0.90 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.33 | -0.31 | -0.96 | -0.86 |
High Estimate | -0.25 | -0.26 | -0.96 | -0.86 |
Low Estimate | -0.33 | -0.31 | -1.20 | -0.95 |
Year ago EPS | -0.35 | -0.26 | -1.35 | -1.11 |
Year over Year Growth Est. | 20.00% | -11.54% | 17.78% | 19.22% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.28 | -0.29 | -1.11 | -0.90 |
7 Days Ago | -0.28 | -0.29 | -1.11 | -0.90 |
30 Days Ago | -0.28 | -0.29 | -1.11 | -0.97 |
60 Days Ago | -0.28 | -0.29 | -1.11 | -0.97 |
90 Days Ago | -0.30 | -0.30 | -1.17 | -1.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.25 | -0.29 | -1.11 | -0.95 |
Zacks Consensus Estimate | -0.28 | -0.29 | -1.11 | -0.90 |
Earnings ESP | 9.64% | 0.00% | 0.00% | -5.95% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.26 | -0.42 | -0.26 | -0.35 | NA |
Estimate | -0.31 | -0.28 | -0.32 | -0.31 | NA |
Difference | 0.05 | -0.14 | 0.06 | -0.04 | -0.02 |
Surprise | 16.13% | -50.00% | 18.75% | -12.90% | -7.01% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more